All Cancer Microbiology articles – Page 5
-
NewsBacteria commonly found in the body contribute to stomach cancer, finds study
A new study has discovered that a type of bacteria commonly found in the body, which usually does not pose problems for healthy people, plays a significant role in causing stomach cancer, the fifth most common cancer in the world.
-
NewsZika virus vaccine emerges as an unlikely hero in battling brain cancer
Scientists have developed a new approach using the Zika virus to destroy brain cancer cells and inhibit tumour growth, while sparing healthy cells.
-
Long ReadsHelicobacter pylori, Cancer and AMR
I’ll begin this article with a question that we’ll return to. Do microorganisms exhibit intelligence? Whilst it might not be able to gauge intelligence in single-celled organisms, a certain intelligent behaviour can be perceived. They possess the simplest chemical signalling pathways, yet are sophisticated enough to evade potential harm.
-
NewsResearchers uncover how virus causes cancer, point to potential treatment
Kaposi sarcoma-associated herpesvirus activates a specific pathway to drive viral persistent infection and cell growth, paving the way for tumors to form.
-
OpinionBacterial pathogens are like cancer, and should be treated as such – with precision
What lessons can be learned about AMR from the development of cancer treatments?
-
NewsUnique tumor-related bacteria tied to young-onset colorectal cancer, study reveals
New research has mapped changes in tumor-related bacteria to uncover potential new strategies to combat the rise of young-onset colorectal cancer (CRC) in people under the age of 50.
-
NewsViruses can cause multiple myeloma cancer, case study finds, offering hope for treatment
An unusual clinical case has led to the discovery that hepatitis B and C viruses are one of the causes of multiple myeloma, and that eliminating infection with antivirals is often the way to fight this type of cancer.
-
NewsZika virus is effective when used to treat a type of childhood cancer in mice
Injecting neuroblastoma tumors with Zika virus shrank or eliminated those tumors in studies with mice, suggesting that the virus could someday serve as an effective cancer therapy, according to a new study.
-
NewsResearchers identify why cancer immunotherapy can cause colitis
Studies in mice reveal the mechanism that induces this severe side effect and point to a solution that kills the cancer without causing gastrointestinal issues.
-
NewsViral enhancement of nanomaterial cancer sensor improves early detection
Researchers have developed an advanced system of breast cancer cell detection with improved speed and sensitivity, using a viral mechanism to enhance the tool’s sensing accuracy.
-
NewsManipulation of gut microbiota with flaxseed could reduce breast cancer risk
Flaxseed components called lignans have been shown to influence the relationship between gut microorganisms and the expression of mammary gland microRNAs.
-
NewsBiomineralized bacterium acts as in-situ vaccine producer
A new type of bacteria-based autologous cancer vaccine uses calcium carbonate (CaCO3) biomineralized Salmonella (Sal) as an in-situ cancer vaccine producer and systematical ITM regulator.
-
NewsMetastasis to be fought with bacteria, hypertension drugs and neuroscience
Results presented by world leaders in metastasis research at CNIO change the very concept of this disease, and lead to new ways to fight it, including using bacteria to activate the immune response against tumours.
-
NewsLactate-producing bacteria inside tumors promote resistance to radiation therapy
Researchers have discovered that lactate-producing intratumoral bacteria drives resistance to radiation therapy, suggesting that lactic acid-producing bacteria present in various cancers may serve as novel therapeutic targets.
-
NewsBat immune genes protect against COVID and cancer
Bats have acquired remarkable traits throughout their evolution. They’re the only mammals that can fly, and they live much longer than other animals their size. But perhaps most impressive is their robust immune system. It protects bats from viruses that wreak havoc in humans, like COVID-19 or Ebola, and also ...
-
NewsEngineered bacteria paint targets on tumors for cancer-killing T cells to see
Columbia engineers are the first to program bacteria to act as beacons that guide the activity of engineered T cells. This work is also the first to design interactions between these two “living” medicines to enable targeting of a range of solid tumor.
-
NewsGut microbiome variations could predict colorectal cancer risk
New research has identified significant variations in the gut microbiome of individuals who developed pre-cancerous colonic lesions, suggesting a potential connection between gut bacteria and the onset of colorectal lesions and cancers.
-
NewsEngineered bacteria guide CAR-T cells to poorly infiltrated solid tumors
A new probiotic-guided chimeric antigen receptor (CAR)-T platform uses engineered bacteria to infiltrate and produce synthetic antigen targets, enabling CAR-T cells to find, identify, and destroy tumor cells in situ, according to a new study.
-
NewsMicrobiome molecule may hamper immune cells’ cancer-fighting abilities
An important group of immune cells in the large bowel - gamma delta T cells - are crucial to preventing bowel cancer, but a molecule linked to gut microbiome diversity may suppress their immune response.
-
NewsOral lipid nanoparticle drug can prevent development of colitis-associated cancer
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University. The findings published in the journal Pharmaceutics report the ...
